What you'll get out of this episode:

• Andy Molnar’s transition from the pharmaceutical industry to DTX.
• The current challenges facing digital therapeutics.
• Predictions for the future of digital health and patient-centric care.

To learn more about Digital Therapeutics Alliance: https://dtxalliance.org/

See more of DTx Equals on our LinkedIn: https://www.linkedin.com/company/dtx-equals
See all episodes of DTx Equals: https://sliceofhealthcare.com/dtx-equals/

WHAT IS SLICE OF HEALTHCARE?
The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

What you'll get out of this episode:
- The importance of merging science and tech in healthcare
- The need for DTX to deliver real patient outcomes
- Overcoming barriers to DTX adoption through education
- The stark differences in U.S. and European startup funding
- How investors are shifting focus towards genuine DTX solutions
- Anish's vision for DTX as a primary treatment option

To learn more about Dopavision: www.gsdhealth.co

See more of DTx Equals on our LinkedIn: https://www.linkedin.com/company/dtx-equals
See all episodes of DTx Equals: https://sliceofhealthcare.com/dtx-equals/

WHAT IS SLICE OF HEALTHCARE?
The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

What you'll get out of this episode:

• Explore DopaVision's digital approach to controlling Myopia in young populations.
• Discussion on digital therapeutics enhancing healthcare delivery.
• Transition from traditional pharmaceuticals to digital therapeutics.
• Mark's journey from Novartis to DopaVision and the potential of digital health.
• Impact of digital therapeutics on routine eye care screenings and treatment access

To learn more about Dopavision: https://dopavision.com/

See more of DTx Equals on our LinkedIn: https://www.linkedin.com/company/dtx-equals
See all episodes of DTx Equals: https://sliceofhealthcare.com/dtx-equals/

WHAT IS SLICE OF HEALTHCARE?
The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

What you'll get out of this episode:

• Learn about the fusion of neuroscience, game design, and digital therapeutics.
• Explore Arcade Therapeutics' mission to transform mental health solutions through game-based digital approaches.
• Discover the journey and motivation behind venturing into digital therapeutics.
• Addressing the challenge: Ensuring scientific rigor in a rapidly advancing tech landscape.
• Insights on the current state and future prospects of Digital Therapeutics (#DTX).
• An engaging recap from the DTX Equals podcast episode.

#DigitalTherapeutics #MentalHealth #ArcadeTherapeutics #NeuroscienceInTech

To learn more about Arcade Therapeutics: https://arcadetherapeutics.com/

See more of DTx Equals on our LinkedIn: https://www.linkedin.com/company/dtx-equals
See all episodes od DTx Equals: https://sliceofhealthcare.com/dtx-equals/

WHAT IS SLICE OF HEALTHCARE?
The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

What you'll get out of this episode:

• Introduction to Digital Therapeutics (#DTX) in the field of mental health.
• Insights from Sona Nevicka-Sikorova, CEO of #MindPax.
• Discussion on the future trajectories of DTX.
• Challenges and innovations in the DTX domain.
• Exploring MindPax's unique approach to patient care.
• The importance of evidence generation in the world of DTX.

To learn more about MINDPAX: https://mindpax.me/

See more of DTx Equals on our LinkedIn: https://www.linkedin.com/company/dtx-equals
See all episodes od DTx Equals: https://sliceofhealthcare.com/dtx-equals/

WHAT IS SLICE OF HEALTHCARE?
The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

#bipolardisorder #psychiatric #mentalhealth 

What you'll get out of this episode:

- Digital Therapeutics transforming healthcare, especially in cognitive health assessments
- Jordan Glenn shifted to cognitive health inspired by a family member's Alzheimer's battle
- Neurotrack focuses on quick, accurate digital cognitive assessments
- Implementing digital therapeutics complex but possible with flexible solutions
- Early diagnosis of cognitive impairment crucial for timely interventions
- Neurotrack offers hope and innovation in managing cognitive impairments

To learn more about Neurotrack: https://neurotrack.com/

See more of DTx Equals on our LinkedIn: https://www.linkedin.com/company/dtx-equals
See all episodes od DTx Equals: https://sliceofhealthcare.com/dtx-equals/

WHAT IS SLICE OF HEALTHCARE?
The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Our Guest Today: Simon Thomas, President at Freespira

What you'll get out of this episode:

• What's a formative event in your life or career that influenced your path in DTX?
• Observations on the ways that FDA is now working with companies now to demonstrate the clinical viability of their product. And any thoughts about how that how that has evolved over time?
• DTX equals what? What's kind of the most defining issue in DTX today from where you're standing?
• What's the relative role of automated technology versus having that human element in terms of achieving the best clinical outcomes?
• Is the goal to basically leave the coach to do the things once everything is automated that can be to do, or is the idea that ultimate technology will catch up to mimicking what a coach does?
• What's something DTX will be able to do in the future that I can't do today?
• What's the gap between in-person interactions and mimicking it in technology that makes it so hard?

To learn more about Simon Thomas and Freespira please use the links below:

- Simon's LinkedIn - Freespira LinkedIn - Freespira Website

Also, be sure to follow DTx Equals on our social channels:

- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter

Our Guest Today: Amber Trivedi, COO at Blue Note Therapeutics

What you'll get out of this episode:

• What is a formative event in your life or career that influenced your path into DTx?
• DTx equals what? What is the most defining issue of DTx today? 
• How much of the problems with DTx getting reimbursment are around pricing? Do you think prices are being set too high, or do you think healthcare needs to readjust? 
• Are there places where healthcare can be disentangled from a human provider? 
• Where do you feel non-human DTx models really shine? 
• In your wildness dreams, what is something DTx will be able to do in the future that it can’t do today?

To learn more about Amber Trivedi and Blue Note Therapeutics please use the links below:

- Amber's LinkedIn - Blue Note Therapeutics LinkedIn - Blue Note Therapeutics Website

Also, be sure to follow DTx Equals on our social channels:

- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter

Our Guest Today: Jorge Palacios, Chief Science Officer at Bright Therapeutics

What you'll get out of this episode:

• What’s a formative event in Palacios' career that influenced his path in DTx, and how saying "yes" shaped his path of opportunity
• What about mental health digital therapeutics excites him 
• "DTx equals" what? What's the most defining issue in DTx today? 
• In his wildest dreams, what's something DTx will be able to do in the future that it can't do today?

To learn more about Jorge Palacios & Bright Therapeutics please use the links below:

- Jorge's LinkedIn - Bright Therapeutics LinkedIn - Bright Therapeutics Website

Also, be sure to follow DTx Equals on our social channels:

- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter

Our Guest Today: Jen Goldsack, Chief Executive Officer at DiMe

What you'll get out of this episode:

• What’s a formative event in Goldsack's life or career that influenced her path in DTx
• "DTx equals" what? What's the most defining issue in DTx today? 
• In her wildest dreams, what's something DTx will be able to do in the future that it can't do today?

To learn more about Jen Goldsack & DiMe please use the links below:

- Jen's LinkedIn - DiMe LinkedIn - DiMe Website

Also, be sure to follow DTx Equals on our social channels:

- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter

Our Guest Today: Whitney Stewart, Director of Clinical Project Management at Curebase

What you'll get out of this episode:

• What’s a formative event in Stewart's life or career that influenced her path in DTx
• "DTx equals" what? What's the most defining issue in DTx today?
• In her wildest dreams, what's something DTx will be able to do in the future that it can't do today?

To learn more about Whitney Stewart & Curebase please use the links below:

- Whitney Stewart LinkedIn - Curebase LinkedIn - Curebase Website

Also, be sure to follow DTx Equals on our social channels:

- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter

Our Guest Today: Jenna Carl, PhD, Chief Medical Officer at Big Health

What you'll get out of this episode:

• What’s a formative event in Carl's life or career that influenced her path in DTx
• "DTx equals" what? What's the most defining issue in DTx today?
• In her wildest dreams, what's something DTx will be able to do in the future that it can't do today?

Please note that this episode contains a brief mention of suicide while discussing mental health treatment. If you want to skip this mention, pause and skip past 11:30-11:37.

To learn more about Jenna Carl & Big Health please use the links below:

- Jenna Carl LinkedIn - Big Health LinkedIn - Big Health Website

Also, be sure to follow DTx Equals on our social channels:

- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter